Overview
Christine Smith is a Hematologist practicing medicine in Nashville, Tennessee.
Dr. Smith is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Febrile Neutropenia, Hodgkin Lymphoma, and Agranulocytosis.
She is actively involved in clinical research, co-authoring 21 peer reviewed articles. Dr. Smith is currently accepting new patients.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
2200 Childrens Way # 6, Nashville, TN 37232
Additional Areas of Focus
Dr. Smith has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Scri Oncology Partners
Erika Hamilton, MD, is an independent medical oncologist and hematologist at Ascension Saint Thomas in Nashville, Tennessee. Dr. Hamilton diagnoses and treats adults with cancer and focuses on managing care during and after chemotherapy, radiation therapy and surgery. Every appointment with Dr. Hamilton starts with a conversation. She takes the time to answer all your questions — big and small. Dr. Hamilton is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, Ovarian Cancer, and HER-2 Positive Breast Cancer. Dr. Hamilton is board certified in The American Board Of Internal Medicine - Medical Oncology. Dr. Hamilton is currently accepting new patients.
Vanderbilt Hematology Clinic
Nishitha Reddy is a Hematologist practicing medicine in Nashville, Tennessee. Dr. Reddy is highly rated in 37 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Reddy is currently accepting new patients.
Scri Oncology Partners
Denise Yardley is a Hematologist and an Oncologist practicing medicine in Nashville, Tennessee. Dr. Yardley is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, and Paget Disease of the Breast. Dr. Yardley is currently accepting new patients.
Frequently Asked Questions about Dr. Christine M. Smith
How do I make an appointment with Dr. Christine M. Smith?
You can book an appointment with Dr. Christine M. Smith by calling their office at 615-322-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Christine M. Smith a top-rated expert for Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christine M. Smith is classified as an Advanced expert for Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Christine M. Smith specialize in?
While Dr. Christine M. Smith is a Hematology, they have specific expertise in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Febrile Neutropenia, and Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Christine M. Smith participate in research or clinical trials?
Yes. Dr. Christine M. Smith has published 21 articles and abstracts on conditions like Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). You can view a list of Dr. Christine M. Smith's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Christine M. Smith accept my insurance?
Dr. Christine M. Smith accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 615-322-5000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Smith isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- AgranulocytosisDr. Smith isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Smith isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- B-Cell LymphomaDr. Smith isExperienced. Learn about B-Cell Lymphoma.
- Burkitt LymphomaDr. Smith isExperienced. Learn about Burkitt Lymphoma.
- Febrile NeutropeniaDr. Smith isExperienced. Learn about Febrile Neutropenia.
- Hemolytic AnemiaDr. Smith isExperienced. Learn about Hemolytic Anemia.
- Hodgkin LymphomaDr. Smith isExperienced. Learn about Hodgkin Lymphoma.
- Non-Hodgkin LymphomaDr. Smith isExperienced. Learn about Non-Hodgkin Lymphoma.
